Related Experiment Videos
Comparative proteomic studies of plasma from children with pneumococcal pneumonia
Ming-Han Tsai1, Tzou-Yien Lin, Sen-Yung Hsieh
1Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan.
Insights
Researchers identified key plasma proteins in children with severe pneumococcal pneumonia. Changes in haptoglobin, immunoglobulin kappa chain, apolipoprotein A-I, and transthyretin suggest an inflammation imbalance in complicated cases.
Area of Science:
- Pediatric Infectious Diseases
- Proteomics
- Immunology
Background:
- Streptococcus pneumoniae is a leading cause of childhood community-acquired pneumonia.
- An unexplained rise in complicated pneumococcal pneumonia necessitates further investigation.
- Understanding protein alterations in severe cases is crucial for diagnosis and treatment.
Purpose of the Study:
- To compare plasma protein profiles in children with complicated versus uncomplicated pneumococcal pneumonia.
- To identify specific protein biomarkers associated with pneumonia severity.
- To elucidate the role of protein changes in the inflammatory response.
Main Methods:
- Analysis of plasma samples from children with varying pneumonia severity using two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS).
- Comparison of protein profiles between complicated pneumonia cases (empyema/necrotizing pneumonitis), uncomplicated cases, and healthy controls.
- Statistical analysis to identify significantly different protein expressions.
Main Results:
- Four proteins showed significant expression differences between pneumonia severity groups.
- Haptoglobin and immunoglobulin kappa chain were upregulated in severe cases.
- Apolipoprotein A-I (Apo-AI) and transthyretin were downregulated in severe cases.
- Identified proteins are involved in inflammation and immune response.
Conclusions:
- Altered plasma protein profiles, including haptoglobin, Apo-AI, transthyretin, and immunoglobulin kappa chain, are associated with complicated pneumococcal pneumonia in children.
- These findings suggest a potential imbalance in the inflammatory response during severe S. pneumoniae infections.
- Haptoglobin's dual role in protecting lung tissue and inhibiting inflammation may be significant in disease pathogenesis.
Abstract:
Streptococcus pneumoniae is the primary pathogen causing community acquired pneumonia in children. Despite medical progress, the prevalence of complicated pneumococcal pneumonia became increased without apparent explanations. Two-dimensional gel electrophoresis (2-DE) and mass spectrometry (MS) were used to compare the plasma protein profiles from children with different severities of pneumococcal pneumonia. Plasma samples from 14 cases, 7 with complicated and the other 7 with uncomplicated pneumonia, were analyzed. Complicated pneumonia was defined by the presence of pleural fluid parameters consistent with empyema, and/or a computed tomography compatible with necrotizing pneumonitis. The normal control group included 7 age-matched volunteers. By comparing the plasma proteins of patients with different severities, 4 proteins with significant differences were identified. The up-regulated proteins were haptoglobin and immunoglobulin kappa chain. The down-regulated were apolipoprotein A-I (Apo-AI) and transthyretin. All these proteins are known to take part in the inflammation reaction, which implicates the active innate immune responses in severe infections of S. pneumoniae. In addition, the up-regulated haptoglobin, which protects lung tissues against oxidative damage by the clearance of hemoglobin, can also act as an inflammatory inhibitor. Thus, our data seem to indicate that inflammation balance may take place in the occurrence of complicated pneumococcal pneumonia.
Related Concept Videos
Pneumonia III: Complications and Assessment
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Pneumonia II: Pathophysiology